{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:09:04Z","timestamp":1791220144406,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.amjcard.2008.02.039","type":"journal-article","created":{"date-parts":[[2008,4,2]],"date-time":"2008-04-02T12:10:21Z","timestamp":1207138221000},"page":"S58-S62","source":"Crossref","is-referenced-by-count":67,"special_numbering":"S","title":["Nicotinic Acid, Alone and in Combinations, for Reduction of Cardiovascular Risk"],"prefix":"10.1016","volume":"101","author":[{"given":"B. Greg","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Qiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2008.02.039_bib1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2008.02.039_bib2","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2008.02.039_bib3","unstructured":"Shepherd J, Betteredge J, Van Gaal L, on behalf of a European Consensus Panel."},{"issue":"suppl","key":"10.1016\/j.amjcard.2008.02.039_bib4","first-page":"S68","article-title":"Dyslipidemia management in adults with diabetes","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2008.02.039_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0002-9149(02)02436-0","article-title":"The role of high density lipoprotein (HDL) cholesterol on the prevention and treatment of coronary heart disease: expert group recommendations","volume":"90","author":"Sacks","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2008.02.039_bib6","first-page":"A1","article-title":"End of drug trial is a big loss for Pfizer","author":"Berenson","year":"2006"},{"key":"10.1016\/j.amjcard.2008.02.039_bib7","first-page":"77","article-title":"Simultaneous LDL-C-lowering and HDL-C-raising for optimum cardiovascular disease prevention with various drug classes, and their combinations","volume":"1","author":"Brown","year":"2007","journal-title":"J Clin Lipidology"},{"key":"10.1016\/j.amjcard.2008.02.039_bib8","series-title":"Atherothrombosis and Coronary Artery Disease","first-page":"153","article-title":"Impact of management on stabilization of plaque and reduction of cardiovascular events","author":"Brown","year":"2005"},{"key":"10.1016\/j.amjcard.2008.02.039_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(91)90500-W","article-title":"Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy","volume":"90","author":"Wilson","year":"1991","journal-title":"Am J Med"},{"issue":"suppl","key":"10.1016\/j.amjcard.2008.02.039_bib10","first-page":"A2","article-title":"The Munster Heart Study (PROCAM): results of follow-up at 8 years","volume":"19","author":"Assman","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2008.02.039_bib11","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.282.24.2340","article-title":"Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials","volume":"282","author":"LaRosa","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2008.02.039_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2008.02.039_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High density lipoprotein cholesterol and cardiovascular disease","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2008.02.039_bib14","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJM199006143222403","article-title":"Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease","volume":"322","author":"Pekkanen","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.02.039_bib15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199011083231901","article-title":"Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B","volume":"323","author":"Brown","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.02.039_bib16","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/01.CIR.88.6.2762","article-title":"Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events","volume":"88","author":"Phillips","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2008.02.039_bib17","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","article-title":"High dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction","volume":"294","author":"Pedersen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2008.02.039_bib18","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.02.039_bib19","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"Major outcomes in moderately hypercholesterolemic hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2008.02.039_bib20","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1001\/jama.1987.03390230069027","article-title":"Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts","volume":"257","author":"Blankenhorn","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2008.02.039_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.0954-6820.1988.tb15891.x","article-title":"Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid","volume":"223","author":"Carlson","year":"1988","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.amjcard.2008.02.039_bib22","unstructured":"Accord Acronym (ACCORD) clinicaltrials.gov Accord #NCT 00000620"},{"key":"10.1016\/j.amjcard.2008.02.039_bib23","unstructured":"AIM-HIGH Acronym (AIM-HIGH) clinicaltrials.gov AIM-HIGH: #NCT 00120289"},{"key":"10.1016\/j.amjcard.2008.02.039_bib24","unstructured":"HPS2-THRIVE Acronym (HPS2-THRIVE) clinicaltrials.gov HPS2-THRIVE #NCT 00461360"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914908002877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914908002877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T10:58:13Z","timestamp":1546167493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914908002877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0002914908002877"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2008.02.039","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}